Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

U.S. stocks open mixed to lower with data ahead; Dow Jones up 0.03%

Published 04/23/2014, 09:43 AM
U.S. stocks mixed to lower before economic reports

Investing.com - U.S. stocks opened mixed to lower on Wednesday, after the release of mixed first-quarter earnings reports and still more to come, whiles investors awaited the release of U.S. economic reports later in the trading session.

During early U.S. trade, the Dow 30 edged up 0.03%, the S&P 500 dipped 0.02%, while the NASDAQ Composite fell 0.22%.

Markets showed little reaction to data earlier showing that the preliminary reading of China’s HSBC manufacturing purchasing managers’ index came in at 48.3 this month, up slightly from a final reading of 48.0 in March, but still below the 50 line separating expansion from contraction.

In th tech sector, Apple (NASDAQ:AAPL) declined 0.57% after data compiled by Bloomberg showed that the company's revenue is projected to be flat this year for the first time in at least a decade, while profit is estimated to decline 5%, making it the sixth consecutive period with little to no gains.

Google (NASDAQ:GOOGL) slid 0.69% aftet the company said its stake in the outcome of a $2 billion trial over smartphones using its Android operating system was revealed by testimony that the company indemnified Samsung Electronics against some of Apple's patent claims.

In earnings news, AT&T (NYSE:T) saw shares dive 3.97% even as the wireless carrier reported first-quarter earnings that exceeded estimates.

Biotech company Amgen (NASDAQ:AMGN) reported lower-than-expected sales of its top drug. Although executives assured investors the drop was seasonal and they were on target to meet their 2014 projections, the company's shares plummeted 2.60% at the open of the U.S. trading session.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In the same sector, Gilead Sciences (NASDAQ:GILD) surged 3.05% after saying that Sovaldi, the company’s $1,000-a-pill medicine to treat hepatitis C, had sales of $2.27 billion in the first quarter, beating analysts' estimates by more than $1 billion.

Elsewhere, Boeing (NYSE:BA) shares advanced 2.22% after the plane manufacturer reported a 14% increase in adjusted net profit in the first quarter, beating market expectations.

Other stocks likely to be in focus included Procter & Gamble (NYSE:PG), Facebook (NASDAQ:FB), Dow Chemical Company (NYSE:DOW), Omnicare (NYSE:OCR), F5 Networks (NASDAQ:FFIV), Zynga (NASDAQ:ZNGA), Texas Instruments (NASDAQ:TXN), Delta Airlines (NYSE:DAL) and QUALCOMM Incorporated (NASDAQ:QCOM), all scheduled to report quarterly results later in the day.

Across the Atlantic, European stock markets were lower. The DJ Euro Stoxx 50 slid 0.36%, France’s CAC 40 declined 0.43%, Germany's DAX fell 0.27%, while Britain's FTSE 100 edged down 0.17%.

During the Asian trading session, Hong Kong's Hang Seng retreated 0.97%, while Japan’s Nikkei 225 rallied 1.09%.

Later in the day, the U.S. was to publish reports on new home sales and manufacturing activity.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.